Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS.
NCT ID: NCT03787420
Last Updated: 2018-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2018-09-01
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
traditional communication system
communication system
We will use the questionnaire "Amyotrophic Lateral Sclerosis Supportive Care Needs ,Amyotrophic Lateral Sclerosis Specific Quality of Life Instrument-Revised, Beck Depression Inventory and Caregiver Burden Scale.
intelligent communication system
communication system
We will use the questionnaire "Amyotrophic Lateral Sclerosis Supportive Care Needs ,Amyotrophic Lateral Sclerosis Specific Quality of Life Instrument-Revised, Beck Depression Inventory and Caregiver Burden Scale.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
communication system
We will use the questionnaire "Amyotrophic Lateral Sclerosis Supportive Care Needs ,Amyotrophic Lateral Sclerosis Specific Quality of Life Instrument-Revised, Beck Depression Inventory and Caregiver Burden Scale.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Degeneration of motor neurons (LMN) by clinical, electrophysiological or neuropathological evidence.
2. Degeneration of upper motor neurons (UMN) is demonstrated by clinical examination.
3. According to the medical history or examination, the symptoms or signs gradually disappear in a certain part.
Also, there are no features:
1. Electrophysiological or pathological evidence of other diseases that may explain signs of LMN and/or UMN degradation
2. Neuroimaging evidence of other diseases that may explain the observed clinical electrophysiological signs.
* Use Mandarin as the main language.
* Age limits minimum is 20
* ALS diagnostic criteria (Brooks et al., 2000).
* Use Mandarin as the main language.
* Age limits minimum is 20
* In everyday oral communication, people who are consciously difficult.
* Ability to perform equipment wear and system operators.
Exclusion Criteria
* The questionnaire cannot be completed without the assistance of others.
Part two:
* Concomitant other central nervous disorders that interfere with their cognitive function, such as dementia, severe depression, and psychosis.
* After correction, the visual acuity cannot see the communication board.
* The scalp is sensitive or there is deep brain stimulation, etc. It is not applicable to brain wave measurement.
* -The questionnaire cannot be completed without the assistance of others.
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cancer Center, Taipei Veterans General Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Cheng Liang Chou
Role: primary
SI-HUEI LEE
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
107-3011-F-027-002-
Identifier Type: -
Identifier Source: org_study_id